Using publicly available translation tables along with clinician and other expertise, we updated the algorithms to include ICD10 codes as additional input variables. We evaluated the performance of ...
BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients ...
WEST LAFAYETTE, Ind. — A Purdue University professor and several international researchers have developed a new method and algorithm that can predict the recurrence of prostate cancer in patients ...
Predictions for identifying 1-year seizure recurrence performed significantly better in electroencephalography (EEG) without interictal epileptiform discharges. An automated processing algorithm ...
Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...
Helsinki, Finland - A new risk model developed by European researchers is able to accurately predict vascular events, including stroke, MI, and vascular death, in patients with existing clinical ...